On Wednesday, the NIH approved thirteen new embryonic stem cell lines for federally-funded research, with ninety-six additional lines still under review. These new approvals come as a direct result of the “Obama administration’s new rules on federal funding for stem cell research, which reversed the Bush policy of prohibiting such funding in most cases.” Read more about the new rules and a dismissed lawsuit against them on Dispatches From the Culture Wars by Ed Brayton. On Framing Science, Matthew C. Nisbet suggests that public attitudes toward stem cells are changing, and reminds us that much of the research currently underway uses stem cells of non-embryonic origin. Then for a different kind of cell line, Abel Pharmboy tells us about Henrietta Lacks on Terra Sigillata, a “woman whose cervical cancer gave rise to the most famous human cancer cell line.” Her cells live on today, as does her story.
Links below the fold.
- Court Dismisses Challenge to Embryonic Stem Cell Research on Dispatches From the Culture Wars
- The Promise, the Hype, and the Reality: It’s a Different Perceptual Era for Embryonic Stem Cell Research on Framing Science
- Meh. What’s so special about HeLa cells? on Terra Sigillata